Chicago Atlantic BDC Boosts Portfolio to $364M, Funds $94M in Q1 2026
Event summary
- Total gross investment income of $16.7M in Q1 2026, with net investment income of $10.0M ($0.44 per share).
- Investment portfolio grew to $364.0M at fair value, a $30.7M increase from the prior quarter.
- Funded seven portfolio companies with $93.9M in aggregate par value, including a $38.3M refinancing to its largest borrower.
- NAV per share increased by $0.03 to $13.33 as of March 31, 2026.
- Board declared a dividend of $0.34 per share for the quarter ending June 30, 2026.
The big picture
Chicago Atlantic BDC's Q1 2026 results highlight its differentiated strategy in the cannabis and lower middle market sectors, despite broader private credit market pressures. The company's record funding and portfolio growth underscore its ability to navigate interest rate uncertainty and dividend coverage concerns. The Federal government's policy shift on medical cannabis adds a strategic tailwind, potentially improving borrower credit quality and industry fundamentals.
What we're watching
- Regulatory Tailwinds
- The Federal government's rescheduling of medical cannabis could enhance borrower credit quality and improve industry fundamentals.
- Portfolio Performance
- The widening of credit spreads during the quarter led to a $1.4M net change in unrealized depreciation, reflecting broader private credit market pressures.
- Capital Flexibility
- The shelf registration statement filed on May 11, 2026, could provide enhanced financial flexibility to issue up to $500M in securities.
Related topics